K-numberK243875
Device nameSpectricept Skin and Wound Cleanser
ApplicantSpectrum Antimicrobials, Inc.
Product codeFRO
Device classClass U
Decision dateApr 21, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Spectricept Skin and Wound Cleanser is a clear hypotonic aqueous solution containing water, hypochlorous acid, and stabilizing chloride salts in an 8 oz non-sterile PET bottle. It is intended for professional and OTC use to cleanse, irrigate, moisten, and remove debris and foreign material from wounds, dermal lesions, pressure ulcers, surgical wounds, burns, abrasions, and minor skin irritations through mechanical action as the fluid moves across the wound bed.

Technological characteristics

The subject device is identical to the predicate in formulation (99.94% water, 0.036% hypochlorous acid, 0.008% each of copper, zinc, and ferric chloride), container closure system (8 oz PET bottle), shelf life (12 months), mechanism of action (mechanical debris removal), sterility status (non-sterile), and antimicrobial effectiveness testing (USP<51>). The only change is labeling to reflect prolonged contact duration (>24 hours to <30 days) rather than limited contact (<24 hours).

Test standards cited

ISO 10993-3 (genotoxicity/carcinogenicity), ISO 10993-5 (in vitro cytotoxicity), ISO 10993-10 (irritation/sensitization), ISO 10993-6 (local effects after implantation), ISO 10993-11 (systemic toxicity), ASTM F756 (hemolytic properties), USP<85> (bacterial endotoxins), and USP<51> (antimicrobial effectiveness).

Substantial equivalence argument

The subject device has identical composition, indications for use, mechanism of action, and technological characteristics to the predicate device K213514. The only modification is the label duration classification, which is supported by additional biocompatibility testing (ISO 10993-6 and ISO 10993-11) demonstrating safety for prolonged contact. Since the device performs the same function with identical formulation and design, and additional testing confirms biocompatibility for the extended contact duration, substantial equivalence is established without raising new safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →